Understanding key healthcare industry issues.
- Webinar: Cultivate your knowledge on the Generics market
Register now for our webinar on the Generics market available on-demand from 14 October 2008.
Oct 12, 2008
- Contracting, rebating, risk-sharing – IMS Conference hears about more innovative approaches to pricing
This year's IMS Pricing & Market Access European Conference was focused on creative solutions to the issue of pharmaceutical pricing.
Sep 24, 2007
- Vaccines:an antidote to sluggish pharma sales?
As the outlook for their sales improves, a number of Big Pharmas are increasing or beginning their development of vaccines.
Sep 4, 2007
- Why simulation?
The advantages of simulation-based training for the pharmaceutical industry.
Jul 4, 2007
- Lifting the lid on key account management
Changes in the prescribing landscape are driving new sales models based on stronger relationships with key prescribers and their influencers.
Jul 3, 2007
- Is personalised medicine getting closer?
Although many drug companies are still hesitant about developing pharmacogenomic products, work in this area is increasing, particularly for cancer.
Feb 7, 2007
- Fewer NMEs, premium launch prices
IMS’ annual review of Pricing and Market Access reveals the continuing poor state of the industry’s ability to launch novel new drugs.
Oct 5, 2006
- Parallel trade: myth versus reality
IMS’ Janice Haigh separates fact from fiction in the contentious issue of pharmaceutical parallel trading.
May 31, 2006
- Medicare Drug Benefit - Progress Report
One of the biggest changes to hit the US healthcare system was a major topic at the recent IMS Cambridge Pharma Consultancy conference.
Apr 3, 2006
- Maximising pharmaceutical ROI among target segments
Delegates at the 2005 Annual Pharmaceutical Marketing ROI Congress in Amsterdam tried a practical approach for success.
Feb 2, 2006
